New Biology
New Biology
  • Home
  • About Us
  • Health Management Centre
  • Natural Health Products
  • Advanced Health Solutions
  • Medical Innovation Digest
  • Contact Us
  • Join Our Team
  • More
    • Home
    • About Us
    • Health Management Centre
    • Natural Health Products
    • Advanced Health Solutions
    • Medical Innovation Digest
    • Contact Us
    • Join Our Team
  • Home
  • About Us
  • Health Management Centre
  • Natural Health Products
  • Advanced Health Solutions
  • Medical Innovation Digest
  • Contact Us
  • Join Our Team

Advanced Ultra-Early Cancer Screening

Detect cancer at its earliest and most treatable stage — before symptoms appear.

What is Ultra-Early Cancer Screening?

Ultra-early cancer screening uses advanced liquid biopsy technology to detect minute traces of circulating tumor DNA (ctDNA) in your blood. This revolutionary method allows for the identification of cancer signals at the molecular level — long before conventional imaging or symptoms can detect abnormalities.

How It Works

  1. Blood Sample: A simple blood draw is taken in a clinical setting.
  2. ctDNA Analysis: The blood is analyzed using next-generation sequencing (NGS) to detect fragmented DNA from potential tumors.
  3. Bioinformatics Review: AI-powered software scans for cancer-specific mutations and epigenetic signatures.
  4. Report & Interpretation: A detailed report is generated and reviewed by an oncologist or specialist.

What Cancers Can Be Detected?

This test can screen for dozens of cancer types, including:

  • Lung cancer
  • Colorectal cancer
  • Liver cancer
  • Pancreatic cancer
  • Breast and ovarian cancer
  • Prostate cancer
  • Gastric cancer
  • And more...

Advantages of Ultra-Early Detection

  • Non-invasive and pain-free (blood draw only)
  • Detects cancer before tumors are visible by imaging
  • Improves prognosis through early intervention
  • Suitable for annual screening in high-risk individuals
  • Customizable to your genetic risk profile

Scientific Evidence

Numerous clinical studies have validated the use of ctDNA testing in cancer detection:

  • Circulating Tumor DNA Analysis in Cancer Management – The New England Journal of Medicine
  • Advances in Liquid Biopsy Technologies for Cancer Detection – PMC
  • Detection and localization of surgically resectable cancers with a multi-analyte blood test – NIH


Who Should Consider This Test?

  • Individuals over 40 years old
  • People with a family history of cancer
  • High-risk individuals (e.g., smokers, heavy alcohol use)
  • Executives and high-stress professionals seeking peace of mind

Booking & Consultation

 Our clinical team at New Biology Group Ltd. is here to guide you. Schedule a consultation to learn how ultra-early screening can be part of your preventative health strategy.

📍 Address: 155 McIntosh Drive, Unit 3

📞 Phone: 437-989-9899

📧 Email: info@newbiology.ca

become a member
  • Home
  • About Us
  • Health Management Centre
  • Natural Health Products
  • Advanced Health Solutions
  • Medical Innovation Digest
  • Contact Us
  • Privacy Policy
  • Join Our Team

New Biology Group Ltd.

155 McIntosh Dr. Unit 3, Markham, ON, L3R 0N6

437-989-9899

Copyright © 2025 New Biology Group Ltd. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept